Tag: GlobalData
AstraZeneca well placed to use Medtech to expand in Chinese healthcare...
The Chinese Internet giants will develop smart health services, AI-assisted screening and diagnosis tools for the British pharma giant...……….
Post NHS approval, sky is the limit for Novartis’ CAR-T therapy:...
According to GlobalData forecasts, the Novartis CAR-T therapy, Kymriah is expected to hit over $1billion sales revenue by 2023 in the US alone......……….
US-China trade war offers window of opportunity for Indian pharma sector
As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..
Regenerative medicine can displace current treatments in CVMD space, says GlobalData
As per the GlobalData, key opinion leaders interviewed by it are eager to have these novel treatments at their disposal, especially for patients with advanced heart failure...………..
Holistic approach may bring true innovation to pharma world, says GlobalData
Major pharma companies are facing massive challenges in developing truly innovative drugs and to minimize risk in internal R&D, they have been mainly relying on outside innovation by biotech firms.................
Artificial intelligence to advance drug discovery
The pharma companies are partnering with artificial intelligence firms in a bid to advance drug discovery............
Malaria eradication a realistic goal in the next 10-15 years, says...
With an estimated 216 million cases of malaria occurring across 91 countries in 2016, halting the transmission of the malaria parasite is a critical step to achieving this goal.................
Healthcare firms finding obesity market a challenge to penetrate, says GlobalData
The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............
Biotech M&A deal activity skyrockets in early 2018, says GlobalData
Many other large pharma firms are expected to join the race and boost their product portfolios through merger and acquisitions, according to GlobalData, a leading data and analytics company...........
Indonesia’s pharma market will reach $12.6 billion by 2020: GlobalData
The research and consulting firm GlobalData has predicted that the pharmaceutical market in Indonesia will reach....